San Francisco, CA11 Active Studies

Hypertension Clinical Trials in San Francisco, CA

Find 11 actively recruiting hypertension clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

11
Active Trials
10
Sponsors
2,008,093
Enrolling

Recruiting Hypertension Studies in San Francisco

NCT07267871Recruiting

Oura Blood Pressure Profile Study

The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in ...

San Francisco, CA2,000,000 participantsOuraring Inc.
View Study Details
NCT04071327Recruiting

Pulmonary Hypertension Association Registry

The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people...

San Francisco, CA3,000 participantsPulmonary Hypertension Association, Inc.
View Study Details
NCT04669548Recruiting

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular ...

San Francisco, CA2,500 participantsPotrero Medical
View Study Details
NCT07218029Recruiting

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lung...

San Francisco, CAPHASE3815 participantsMerck Sharp & Dohme LLC
View Study Details
NCT04967989Recruiting

Clarifying the Optimal Application of SLT Therapy Trial

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or d...

San Francisco, CAPHASE3790 participantsUniversity of Pittsburgh
View Study Details
NCT06059638Recruiting

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-c...

San Francisco, CANA500 participantsOrchestra BioMed, Inc
View Study Details
NCT05983250Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....

San Francisco, CAPHASE3230 participantsTenax Therapeutics, Inc.
View Study Details
NCT05843500Recruiting

Chronic Thromboembolic Disease Registry

The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main que...

San Francisco, CA100 participantsUniversity of California, San Francisco
View Study Details
NCT06129240Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH....

San Francisco, CA80 participantsLiquidia Technologies, Inc.
View Study Details
NCT05587712Recruiting

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World ...

San Francisco, CAPHASE242 participantsMerck Sharp & Dohme LLC
View Study Details
NCT07073820Recruiting

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is h...

San Francisco, CAPHASE236 participantsPfizer
View Study Details

About Hypertension Clinical Trials in San Francisco

Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.

There are currently 11 hypertension clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 2,008,093 participants. Research is being sponsored by Ouraring Inc., Pulmonary Hypertension Association, Inc., Potrero Medical and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hypertension Clinical Trials in San Francisco — FAQ

Are there hypertension clinical trials in San Francisco?

Yes, there are 11 hypertension clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What hypertension treatments are being tested?

The 11 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.

Data updated July 17, 2026 from ClinicalTrials.gov